BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38170920)

  • 1. A Comparison of 18 F-FDG PET/CT and 68 Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer.
    Öztürk AE; Şahin R; Ergül N; Çermik TF; Arslan E
    Clin Nucl Med; 2024 Feb; 49(2):e68-e69. PubMed ID: 38170920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
    Kim Y; Lee HY; Yoon HJ; Kim BS
    J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68 Ga-FAPI PET/CT Detected Non-PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer.
    Pang Y; Meng T; Xu W; Shang Q; Chen H
    Clin Nucl Med; 2022 Dec; 47(12):1108-1111. PubMed ID: 35961368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory analysis of 64 CuCl 2 PET-CT imaging in carcinoma prostate and its comparison with 68 Ga-PSMA-11 and 18 F-FDG PET-CT.
    Nazar AK; Kalshetty A; Chakravarty R; Chakraborty S; Basu S
    Nucl Med Commun; 2023 Oct; 44(10):910-923. PubMed ID: 37578310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer.
    Tatar G; Ergül N; Baloğlu MC; Arslan E; Çermik TF
    Clin Nucl Med; 2023 Mar; 48(3):e135-e137. PubMed ID: 36723899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of
    Chen R; Wang Y; Shi Y; Zhu Y; Xu L; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2970-2977. PubMed ID: 33528607
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Qi Z; Yao X; Su M; Huang R
    Hell J Nucl Med; 2023; 26(2):155-156. PubMed ID: 37527052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT.
    Cai J; Xu W; Meng T; Pang Y; Chen H
    Clin Nucl Med; 2023 Aug; 48(8):743-745. PubMed ID: 37220226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Parghane RV; Basu S
    J Nucl Med Technol; 2023 Sep; 51(3):261-262. PubMed ID: 36041875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FDG PET/CT in Management of Patients with Prostate Cancer.
    Sutherland DEK; Azad AA; Murphy DG; Eapen RS; Kostos L; Hofman MS
    Semin Nucl Med; 2024 Jan; 54(1):4-13. PubMed ID: 37400321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68 Ga-PSMA-11 and 18 F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate.
    Qiu S; Dong A; Zhu Y; Zuo C
    Clin Nucl Med; 2022 Sep; 47(9):836-838. PubMed ID: 35439204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Trial of
    Wang B; Liu C; Wei Y; Meng J; Zhang Y; Gan H; Xu X; Wan F; Pan J; Ma X; Hu S; Freedland SJ; Song S; Ye D; Zhu Y
    Clin Cancer Res; 2020 Sep; 26(17):4551-4558. PubMed ID: 32527944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68 Ga-PSMA-Avid Liver Metastases From Colon Cancer, Not Visualized on FDG PET Scan.
    Doroudinia A; Chekuri S
    Clin Nucl Med; 2023 Nov; 48(11):e547-e548. PubMed ID: 37756469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
    Chalikandy A; Yadav S; Basu S
    J Nucl Med Technol; 2023 Dec; 51(4):339-342. PubMed ID: 37586854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.